| Added by | standudu |
|---|---|
| Group name | EquipeCTCS |
| Item Type | Journal Article |
| Title | Targeting triple-negative breast cancer and high-grade ovarian carcinoma: refining BRCAness beyond BRCA1/2 mutations? |
| Creator | Jacot et al. |
| Author | W. Jacot |
| Author | C. Theillet |
| Author | S. Guiu |
| Author | P. J. Lamy |
| Publication | Future Oncol |
| Volume | 11 |
| Pages | 557-9 |
| Date | 2015 |
| Journal Abbr | Future oncology |
| DOI | 10.2217/fon.14.268 |
| ISSN | 1744-8301 (Electronic) 1479-6694 (Linking) |
| Tags | *Molecular Targeted Therapy, Antineoplastic Agents/pharmacology/therapeutic use, corresponding, DNA Damage/drug effects, Female, first, first-last-corresponding, Genes, BRCA1, Genes, BRCA2, Genomic Instability/drug effects, Humans, Mutation, Neoplasm Grading, Ovarian Neoplasms/*drug therapy/*genetics/pathology, Poly(ADP-ribose) Polymerases/antagonists & inhibitors, review, Triple Negative Breast Neoplasms/*drug therapy/*genetics/pathology |
| Date Added | 2018/11/14 - 15:25:02 |
| Date Modified | 2022/08/01 - 16:10:33 |
| Notes and Attachments | (Note) (Note) 25686112 (Attachment) |
Institut de Recherche en Cancérologie de
